Thomas Kazmirchuk on AI-Generated Peptide Targeting Platelet-type von Willebrand Disease
Thomas Kazmirchuk, Associate Research Fellow at Queen’s University, shared on LinkedIn:
”I am absolutely thrilled to share that my study on how we designed, screened, validated, and confirmed peptides with therapeutic and diagnostic utility in Platelet-type von Willebrand disease that was accepted in Blood Advances is now available online as a first edition!
This work brought together many disciplines from biochemistry, AI, hematology, and others to address a critical need in PT VWD and bleeding disorders as a whole.
Thank you to Ashkan Golshani, Dr. Maha Othman MD MSc PhD for your endless support during this project.
I would also like to thank our collaborators in Dr. Gresele’s lab at the University of Perugia for their assistance.
And thank you to the expert reviewers and of course the editorial staff at the American Society of Hematology’s Blood Advances.
The future is bright for hematology, medicine, and those with bleeding disorders.”
Read the full paper here.
Article: Developing an AI-Generated Peptide Targeting Platelet-type von Willebrand Disease
Authors: Thomas David Daniel Kazmirchuk, Jiashu Wang, Loredana Bury, Emanuela Falcinelli, Calvin Bradbury-Jost, Anastasiia Koziar, Mustafa Al-gafari, Sarah Takallou, William G Willmore, Frank Dehne, Paolo Gresele, Maha Othman, Ashkan Golshani
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Dec 19, 2025, 12:03Pradeep Natarajan: Our New Genetic Study of Aortic Stenosis in ~3M
-
Dec 19, 2025, 11:47ESO Blog: Anna Gardin on Stroke Risk in the Era of Climate Extremes
-
Dec 19, 2025, 10:51Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
-
Dec 19, 2025, 10:08Camilla Lombardi Shares an EHC Nutrition Guide for People with Bleeding Disorders
-
Dec 19, 2025, 09:56Danny Hsu Shares The ”I-WISh” Study by Nichola Cooper on ITP
-
Dec 19, 2025, 09:39Paul Bolaji: A Landmark Achievement -The Historic 1st Nigerian Stroke Leaders’ Summit 2025
-
Dec 19, 2025, 09:24Zain Khalpey on A New Study Linking Low-dose Aspirin to Reduced Cancer Spread
-
Dec 19, 2025, 06:13Anna Aldehag Reflects on Her 12 Year Leadership in Sweden National Board of Health and Welfare
-
Dec 19, 2025, 05:54Abdul Mannan: APTT Mixing Studies Confuse a Lot of People